Cargando…
Association Between Cancer-Related Fatigue and Falls in Patients With Myeloproliferative Neoplasms: Results of a Multicenter Cross-Sectional Survey From the East German Study Group for Hematology and Oncology (OSHO #97)
OBJECTIVE: This study retrospectively examined the association between cancer-related fatigue (CrF) and the number of falls during the last 12 months in patients with myeloproliferative neoplasms (MPNs). METHODS: A multicenter, 1-time anonymous survey was conducted using analog and digital questionn...
Autores principales: | Felser, Sabine, Gube, Martin, Gruen, Julia, Coutre, Philipp Ie, Schulze, Susann, Muegge, Lars-Olof, Junghanss, Christian, Ulbricht, Sabina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791269/ https://www.ncbi.nlm.nih.gov/pubmed/36539979 http://dx.doi.org/10.1177/15347354221143064 |
Ejemplares similares
-
Anxieties, age and motivation influence physical activity in patients with myeloproliferative neoplasms - a multicenter survey from the East German study group for hematology and oncology (OSHO #97)
por: Felser, Sabine, et al.
Publicado: (2023) -
Physical exercise recommendations for patients with polycythemia vera based on preferences identified in a large international patient survey study of the East German Study Group for Hematology and Oncology (OSHO #97)
por: Felser, Sabine, et al.
Publicado: (2023) -
Longitudinal Humoral and Cellular Immune Responses Following SARS-CoV-2 Vaccination in Patients with Myeloid and Lymphoid Neoplasms Compared to a Reference Cohort: Results of a Prospective Trial of the East German Study Group for Hematology and Oncology (OSHO)
por: Jotschke, Sabrina, et al.
Publicado: (2022) -
Osho - Insights on sex
por: Nagaraj, Anil Kumar Mysore
Publicado: (2013) -
Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials
por: Heinicke, Thomas, et al.
Publicado: (2021)